Abstract
Cancer drug response prediction is the fundamental task in precision medicine, which provides opportunities for cancer therapy. Several methods have been proposed to screen drugs, via building computational models on multi-omics data. However, the view value missing problem caused by unknown cancers or tumors has not been addressed. For this reason, a multi-view multi-omics (MvMo) model is proposed to predict cancer drug response values. The proposed MvMo model first represents the input heterogeneous data in different kinds of embeddings and features, such as token embeddings and latent features. Then several views are generated to observe interconnections among those representations. Finally, the predictions are generated based on the outputs of these views. Experimental results on the collected real data show the efficiency of the proposed method in terms of speed and accuracy.





Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Adam G, Rampasek L, Safikhani Z, Smirnov P, Haibe-Kains B, Goldenberg A (2020) Machine learning approaches to drug response prediction: challenges and recent progress. NPJ Precis Oncol 4 (1):19
Ali M, Aittokallio T (2019) Machine learning and feature selection for drug response prediction in precision oncology applications. Biophys Rev 11(1):31–39
Baptista D, Ferreira PG, Rocha M (2021) Deep learning for drug response prediction in cancer. Brief Bioinform 22(1):360–379
Basu A, Mitra R, Liu H, Schreiber SL, Clemons PA (2018) RWEN: response-weighted elastic net for prediction of chemosensitivity of cancer cell lines. Bioinformatics 34(19):3332–3339
Chang Y, Park H, Yang HJ, Lee S, Lee KY, Kim TS, Jung J, Shin JM (2018) Cancer drug response profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature. Sci Rep 8(1):8857
Chao G, Sun S (2018) Semi-supervised multi-view maximum entropy discrimination with expectation laplacian regularization. Inf Fusion 45(2):296–306
Chen J, Zhang L (2021) A survey and systematic assessment of computational methods for drug response prediction. Brief Bioinform 22(1):232–246
Cichonska A, Pahikkala T, Szedmak S, Julkunen H, Airola A, Heinonen M, Aittokallio T, Rousu J (2018) Learning with multiple pairwise kernels for drug bioactivity prediction. Bioinformatics 34:509–518
Costello JC, Heiser LM, Georgii E, Gönen M, Menden MP, Wang NJ, Bansal M, Hintsanen P, Khan SA, Mpindi JP et al (2014) A community effort to assess and improve drug sensitivity prediction algorithms. Nat Biotechnol 32(12):1202–1212
Ammad-ud din M, Georgii E, Gonen M, Kallioniemi O, Wennerberg K, Poso A (2014) Integrative and personalized QSAR analysis in cancer by kernelized bayesian matrix factorization. J Chem Inf Model 54:35
Ammad-ud din M, Khan SA, Malani D, Murumägi A, Kallioniemi O, Aittokallio T, Kaski S (2016) Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization. Bioinformatics 32(17):i455–i463
Ammad-ud din M, Khan SA, Wennerberg K, Aittokallio T (2017) Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression. Bioinformatics 33(14):i359–i368
Geeleher P, Cox NJ, Huang R (2014) Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol 15(3):R47
He X, Folkman L, Borgwardt K (2018) Kernelized rank learning for personalized drug recommendation. Bioinformatics 34(16):2808–2816
Kingma DP, Ba J (2015) Adam: A method for stochastic optimization. In: Proceedings of the 3rd international conference on learning representations. OpenReview.net, San Diego, CA, USA
Li M, Wang Y, Zheng R, Shi X, Li Y, Wu FX, Wang J (2021) Deepdsc: A deep learning method to predict drug sensitivity of cancer cell lines. IEEE/ACM Trans Comput Biol Bioinform 18 (2):575–582
Liu Q, Hu Z, Jiang R, Zhou M (2020) DeepCDR: a hybrid graph convolutional network for predicting cancer drug response. Bioinformatics 36(Supplement_2):911–918
Rahman R, Matlock K, Ghosh S, Pal R (2017) Heterogeneity aware random forest for drug sensitivity prediction. Sci Rep 7(1):11347
Riddick G, Song H, Ahn S, Walling J, Borges-Rivera D, Zhang W, Fine HA (2010) Predicting in vitro drug sensitivity using random forests. Bioinformatics 27(2):220–224
Sharifi-Noghabi H, Zolotareva O, Collins C, Ester M (2019) Moli: multi-omics late integration with deep neural networks for drug response prediction. Bioinformatics 35:501–509
Snow O, Sharifi-Noghabi H, Lu J, Zolotareva O, Lee M, Ester M (2021) Interpretable drug response prediction using a knowledge-based neural network. In: Proceedings of the 27th international conference on knowledge discovery and data mining. ACM, New York, NY, USA, pp 3558–3568
Sokolov A, Carlin DE, Paull EO, Baertsch R, Stuart JM (2016) Pathway-based genomics prediction using generalized elastic net. PLoS Comput Biol 12(3):1–23
Sotudian S, Paschalidis IC (2021) Machine learning for pharmacogenomics and personalized medicine: A ranking model for drug sensitivity prediction. IEEE/ACM Trans Comput Biol Bioinform:1–1
Suphavilai C, Bertrand D, Nagarajan N (2018) Predicting cancer drug response using a recommender system. Bioinformatics 34(22):3907–3914
Wang L, Li X, Zhang L, Gao Q (2017) Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization. BMC Cancer 17(1):513
Wang Z, He L (2016) User identification for enhancing IP-TV recommendation. Knowl-Based Syst 98:68–75
Wang Z, Chen K, He L (2018) Asysim: modeling asymmetric social influence for rating prediction. Data Sci Pattern Recog 2:25–40
Ye Q, Hsieh CY, Yang Z, Kang Y, Chen J, Cao D, He S, Hou T (2021) A unified drug–target interaction prediction framework based on knowledge graph and recommendation system. Nat Commun 12(1):6775
Zhang F, Wang M, Xi J, Yang J, Li A (2018) A novel heterogeneous network-based method for drug response prediction in cancer cell lines. Sci Rep 8(1):3355
Zhang N, Wang H, Fang Y, Wang J, Zheng X, Liu XS (2015) Predicting anticancer drug responses using a dual-layer integrated cell line-drug network model. PLoS Comput Biol 11(9):18
Zou H, Hastie T (2005) Regularization and variable selection via the elastic net. J R Stat Soc 67(2):301–320
Acknowledgements
This work was supported in part by Jimei University (no. ZP2021013), the Science project of Xiamen City (no. 3502Z20193048), the Education Department of Fujian Province (CN) (no. JAT200277), and the Natural Science Foundation of Fujian Province (CN) (no. 2021J01859).
We would like to thank the editor and anonymous reviewers for their helpful comments in improving the manuscript quality.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article belongs to the Topical Collection: Special Issue on Multi-view Learning Guest Editors: Guoqing Chao, Xingquan Zhu, Weiping Ding, Jinbo Bi and Shiliang Sun
Rights and permissions
About this article
Cite this article
Wang, Z., Wang, Z., Huang, Y. et al. A multi-view multi-omics model for cancer drug response prediction. Appl Intell 52, 14639–14650 (2022). https://doi.org/10.1007/s10489-022-03294-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10489-022-03294-w